Research | Open | Published:
Manipulation of the carbon storage regulator system for metabolite remodeling and biofuel production in Escherichia coli
Microbial Cell Factoriesvolume 11, Article number: 79 (2012)
Microbial engineering strategies that elicit global metabolic perturbations have the capacity to increase organism robustness for targeted metabolite production. In particular, perturbations to regulators of cellular systems that impact glycolysis and amino acid production while simultaneously decreasing fermentation by-products such as acetate and CO2 make ideal targets. Intriguingly, perturbation of the Carbon Storage Regulator (Csr) system has been previously implicated in large changes in central carbon metabolism in E. coli. Therefore, we hypothesized that perturbation of the Csr system through the CsrA-CsrB ribonucleoprotein complex might increase production of biofuels and their intermediates from heterologous pathways.
We engaged the CsrA-CsrB ribonucleoprotein complex of E. coli via overexpression of CsrB. CsrB is a 350-nucleotide non-coding RNA that antagonizes CsrA, an RNA-binding protein that regulates translation of specific mRNA targets. By using shotgun proteomics and targeted metabolomics we established that elevation of CsrB levels leads to alterations in metabolite and protein levels in glycolysis, the TCA cycle and amino acid levels. Consequently, we show that such changes can be suitably applied to improve the production of desired compounds through the native fatty acid and heterologous n-butanol and isoprenoid pathways by up to two-fold. We also observed concomitant decreases in undesirable fermentation by-products such as acetate and CO2.
We have demonstrated that simple engineering of the RNA-based Csr global regulatory system constitutes a novel approach to obtaining pathway-independent improvements within engineered hosts. Additionally, since Csr is conserved across most prokaryotic species, this approach may also be amenable to a wide variety of production hosts.
Strategies for increasing organism robustness and product formation by manipulation of non-pathway components have gained traction in recent years . Prominent examples include the reprogramming of transcriptional machinery achieved by varying the concentration or sequence of sigma factor proteins or the perturbation of regulators that alter cellular metabolism [2–5]. Arguably, the ideal perturbation(s) would lead to higher product formation by altering central carbon metabolism, result in higher amino acid production for the biogenesis of heterologous proteins, and reduce fermentation by-products such as CO2 and acetate that decrease product yield. In this study, we examined the carbon storage regulator (Csr) system of E. coli as one potential system that could be manipulated to bring about such changes.
The carbon storage regulator (Csr) system of E. coli has been shown to regulate over 700 genes and can exert control over global regulatory systems, such as the stringent response . Csr influences a number of physiological processes including central carbon metabolism, biofilm development, motility, peptide uptake, and virulence gene expression [7–10]. Interestingly, manipulation of Csr has also been demonstrated to increase production of phenylalanine [11, 12]. As such, Csr is a key cellular subsystem that might be exploited for increased production of compounds from both native and heterologous pathways.
Csr is controlled by the RNA-binding protein CsrA [13–15], which binds to the 5’ untranslated region of its target mRNAs, often in the region spanning the Shine-Dalgarno (SD) site  (Figure 1A). Interaction of CsrA with mRNA interferes with ribosome binding, negatively impacting translation of target transcripts. While CsrA directly regulates the activity of glycolysis pathway components both positively (glucose-6-phosphate isomerase (pgi), triose-phosphate isomerase (tpiA), and enolase (eno)) and negatively (fructose-1,6-bisphosphatase (fbp) and phosphoenolpyruvate synthetase (pps)) , CsrA is essential to E. coli during growth on glycolytic carbon sources due to its ability to limit glycogen accumulation . Regulation of CsrA can occur by physical interaction with CsrB, a non-coding small RNA [19–21]. CsrB prevents CsrA from binding target transcripts thus alleviating CsrA-induced translation inhibition (Figure 1A). In fact, it has been proposed that the intracellular level of CsrB is the key determinant of CsrA activity in the cell .
As Csr regulates a wide variety of cellular processes including parts of central carbon metabolism, we hypothesized that manipulation of CsrB expression might alter the activity of CsrA resulting in changes to E. coli metabolism favorable to product formation. To investigate this possibility, we evaluated the effects of CsrB elevation on the proteome, on metabolites of central carbon metabolism, and on the production of several advanced biofuels or their precursors in E. coli. We demonstrate that the Csr system can serve as an effective regulatory handle for improving production via a number of engineered pathways, reducing the need for extensive host-chromosome modifications.
CsrB-mediated proteome changes
We reasoned that since CsrB regulatory control occurs at the post-transcriptional level, quantitative proteomic measurements would offer the most direct assessment of relevant cellular changes. Therefore, we employed a shotgun proteomics approach to compare protein levels in E. coli with elevated CsrB levels to those from an uninduced control. We chose to profile cells during stationary phase when Csr is most active in remodeling cellular metabolism . This also corresponds to when engineered bacteria are typically harvested for biofuel production.
E. coli (see Additional file 1: Table S1) with or without elevated CsrB levels were grown in Neidhardt’s MOPS medium with IPTG for 24 hours, and harvested for proteomic analysis. At a 95% confidence interval, 894 proteins (~20% genomic coverage) were identified with at least two peptides (Figure 1B). Candidates with an average of five or more normalized spectral counts in the induced samples and at least a 2-fold change upon induction are listed in Additional file 2: Table S2 (see Additional file 3: Table S5 for the complete list of proteins identified in this study). We confirmed increased protein levels of known CsrA mRNA targets glgB, glgC, and ompA (Additional file 2: Table S2), which upon CsrB elevation were observed to rise 16.7-, 4.5-, and 2.8-fold respectively.
Using TIGR Gene Indices and gene ontology (GO) categories that provide genome-wide functional annotations for related genes , we observed that CsrB elevation significantly affected the protein abundance of several functional categories (P < 0.05, multiple-test corrected hypergeometric enrichment test). Many of the proteins in TIGR categories such as ‘Energy metabolism’, ‘glycogen biosynthetic process’, and ‘amino acid biosynthesis’ displayed CsrB-dependent expression changes that were greater than twice the level observed for the control strain. In particular, we noted several proteins involved in central carbon metabolism – Pck, TpiA, GapA, and Eno from glycolysis/gluconeogenesis, the SdhAB and SucABCD operons associated with the TCA cycle as well as TktA, TalB, and AtpG involved in the pentose phosphate pathway showed significant changes in protein expression. Consistent with these results, we also observed that genes under the regulatory control of CysB  were significantly overrepresented (P < 0.05) among proteins with altered expression. CysB has been previously implicated in modulating carbon source utilization during limited nutrient availability .
Additionally, proteins with altered expression also included those associated with stress response (PspA, GrpE, AhpC), transport (CysA, TolC, SecB), and regulatory functions (DksA, RraA, AllR). In particular, the change in protein expression of DksA corroborates a previously proposed regulatory interaction between Csr and stringent response  (Additional file 4: Figure S1A). Currently, the stringent response transcription factor DksA and the nucleotide secondary messenger ppGpp are thought to activate Csr by increasing transcription of csrB/C through BarA/UvrY, thereby relieving CsrA-mediated repression during the stringent response . However, it was also reported that CsrA has only a modest effect on DksA gene expression. In contrast, we observed a greater than 2.5-fold increase in the expression of DksA upon CsrB elevation suggesting a more substantial role for CsrA regulation of DksA expression.
RNA-binding motifs of CsrA
Given the technical limitations of shotgun proteomics (limited to 20% genomic coverage in this study) we wanted to assess the broader impact of perturbing CsrA-mediated regulation in E. coli. Therefore, to identify putative CsrA-regulated genes, we investigated the distribution of three variants of an 8-base pair (bp), position-independent, degenerate CsrA binding motif within a 22-bp window upstream of the translational start site of each E. coli gene (see Supplemental Methods for details on motif generation). The first motif was derived directly from experimentally determined binding sites (Motif 0: [~G]ANGGAN[A/U]). We further refined Motif 0 to generate Motif 1: [~G]A[~C]GGA[~C][A/U] and Motif 8:[~G]A[~C]GGA[~C][~G]), which showed the highest combination of sensitivity and specificity (Additional file 4: Figure S1B,C) for proteins identified by our mass spectrometry experiments.
Our search discovered hundreds (Motif 0: 689 genes, Motif 1: 575 genes, Motif 8: 702 genes) of protein-coding genes that possess putative sites immediately upstream of their translational start (Additional file 5: Table S4, Additional file 3: Table S5). Examining the set of differentially expressed proteins from our screen revealed that they were significantly enriched for these motifs (P < 0.02, hypergeometric enrichment test). Among these genes, we identified previously reported targets with roles in glycogen synthesis, peptidoglycan formation, peptide import, and RNA metabolism [7, 14]. Interestingly, we also identified CsrA-binding sites among genes responsible for chaperones involved in the general stress response of E. coli, iron homeostasis, and transcriptional and translational regulators. These observations suggest that Csr regulates additional functions than what has been described so far .
Next, we examined our proteomics results in conjunction with previously derived TF regulons . While we found several regulons with genes that possessed CsrA binding sites, several regulons also had the cognate transcription factor itself under putative CsrA regulation. Examples of such systems include those involved in carbon utilization, stress response, and regulation of quorum sensing and biofilms. In particular, we noted that the FabR/FadR regulons were also putatively CsrA-regulated. These regulons directly impact fatty acid biosynthesis and the AtoC regulon, which includes AtoB, a key enzyme for acetoacetyl-CoA synthesis. As such, these regulons are critical for pathway engineering applications that rely on acetyl-CoA as a branch point metabolite.
CsrB-mediated alterations in central carbon metabolism
From the shotgun proteomics measurements, we noted changes in levels of several proteins from glycolysis/gluconeogenesis, the TCA cycle, and the pentose phosphate pathway upon CsrB elevation. Additionally, our genome wide survey of CsrA binding motifs suggested a potential impact on the AtoC regulon, which affects acetyl-CoA levels. Consequently, we proceeded to examine the direct impact of perturbing CsrB levels on intracellular metabolites associated with central carbon metabolism. E. coli with or without elevated CsrB levels were grown in Neidhardt’s MOPS medium with IPTG (50 μ M) and harvested after 48 hrs. All measurements were performed with liquid chromatography and mass spectrometry analysis except for amino acid metabolites that were determined by capillary electrophoresis and mass spectrometry.
Intracellular concentrations of twenty-four of the thirty-four metabolites analyzed were elevated, with nine intermediates demonstrating increases greater than six-fold (Figure 2). Notably intracellular levels of lower half glycolytic intermediates glycerol-3-phosphate (G3P), 3-phosphoglycerate (3PG) and/or 2-phosphoglycerate (2PG), phosphoenolpyruvate (PEP), and pyruvate (pyr) were three- to eight-fold higher in cultures with elevated CsrB than in control cultures. Intriguingly, intracellular pools of acetyl-CoA increased eight fold. Acetyl-CoA is a vital precursor to several pathways relevant to product formation in host organisms and is likely a bottleneck to further increases in production hosts.
In contrast to the comprehensive effect observed on lower half glycolytic intermediates due to CsrB elevation, the impact on the TCA cycle appeared to be more restricted (Figure 2, Additional file 6: Table S3). We observed greater than five-fold increases in oxaloacetate (OAA), malate (MAL), fumarate (FUM), succinate (SUC), and glyoxylate in cells with elevated CsrB. Despite higher levels of these intermediates as well as acetyl-CoA, concentrations of citrate and/or isocitrate (I-CIT), and α-ketoglutarate (α-KG) were unaffected upon CsrB elevation (Figure 2, Additional file 6: Table S3).
We also examined levels of extracellular metabolites - glucose and acetate - in the culture medium over the course of 24-hours growth. Despite increased PEP levels, we found that CsrB induction led to a decrease in glucose consumption (Figure 3). This could not be explained by differences in cell-culture density since optical density (OD600) measurements were virtually indistinguishable between control and induced strains. In contrast, acetate, which is formed due to overflow metabolism, decreased as a function of CsrB expression (Figure 3). The decrease in extracellular acetate levels along with decreased glucose consumption levels might partly explain the carbon redistribution of intracellular metabolites described above. Additional studies on other extracellular metabolites would further shed light on the metabolic impact of CsrB, but are beyond the scope of this work. In particular, we were intrigued by the rise in intracellular glyoxylate levels upon CsrB elevation, which may have a bearing on CO2 secretion .
CsrB-mediated alterations in amino acid levels
Increased amino acid production would be expected to benefit a host organism by increasing the ability to produce both native and heterologous proteins and hence enhance product formation. While manipulation of Csr has been previously demonstrated to increase production of phenylalanine [11, 12], its impact on other amino acids has not been measured. In this study, we performed a comprehensive analysis of cellular amino-acid levels in a strain with elevated CsrB levels versus a control. Consistent with previous reports, we observed a 2.5-fold increase in phenylalanine levels. Examining the levels of other amino acids, we observed even larger changes in the levels of asparagine, threonine and aspartate which increased 47-, 30- and 9-fold, respectively (Additional file 6: Table S3).
Interestingly, from our central carbon metabolomics data we observed insignificant changes in α-KG levels. As α-KG is a TCA cycle intermediate and a precursor for the amino acids glutamate, glutamine, and proline, we would expect to see no changes in the levels of these amino acids. Surprisingly, we observed substantial increases in glutamate, glutamine, and proline levels (Additional file 6: Table S3). Additionally, amino acids derived from glycolytic intermediates that do not involve the TCA cycle (serine, glycine and alanine) were also found at higher levels as a result of CsrB elevation (Additional file 6: Table S3).
Elevation of CsrB levels in E. coli improves production via engineered biofuel pathways
Our shotgun proteomics and targeted metabolomics data suggests that manipulation of Csr leads to accumulation of glycolytic and TCA cycle intermediates, decreased levels of fermentation by-products, and improved levels of both chaperones and DNA repair enzymes. These characteristics are highly desirable in the engineering of metabolic pathways. However, most strategies employed for improving compound production from metabolic pathways have primarily relied on manipulating the components of the pathways themselves [29–31]. Therefore, we wanted to test whether perturbing this global regulator rather than pathway components themselves might lead to improved production characteristics. Consequently, we tested the ability of increased CsrB levels to improve production of advanced biofuels and their precursors that have been targeted in recent metabolic engineering studies [32, 33]. Specifically, we tested production from the native fatty acid (FA) pathway of E. coli, the n-butanol pathway (from Clostridium acetobutylicum), and the mevalonate pathway (from Saccharomyces cerevisiae).
FA biosynthesis commences with acetyl-CoA and malonyl-CoA as precursors followed by a series of condensation and elongation steps. Each step of the elongation cycle adds two carbons to a growing fatty acid- acyl carrier protein chain (Figure 4). Our binding site analysis suggests that translation of at least two known regulators of fatty acid metabolism, FabR and FadR, may be controlled by CsrA (Additional file 5: Table S4). FabR modulates fabB and fabA expression to balance the unsaturated:saturated FA ratio of acyl chains . In contrast, the dual regulator FadR functions as a switch that coordinately regulates the machinery required for fatty acid β-oxidation and the expression of a key enzyme in FA biosynthesis . FadR also represses the entire set of degradative (fad) genes but activates the expression of fabA.
Consequently, we hypothesized that Csr regulation of FabR and FadR, along with an elevated level of acetyl-CoA afforded by CsrB upregulation might impact both FA levels as well as the degree of saturation. We tested this hypothesis in a strain overexpressing a leaderless version of the tesA product (`TesA) with either CsrB or an empty plasmid control. Cytosolically localized `TesA can act on a range of acyl-CoA molecules to produce free fatty acids (FFAs) and FA ethyl esters [37–40]. E. coli overexpressing `TesA and elevated CsrB produced 76% more saturated and unsaturated FAs than control cultures bearing `TesA and an empty plasmid control (from 233 mg/L to 430 mg/L in 48 h) (Figure 4a). CsrB-mediated regulation improved total production of C12, C14, C16:1, C16, and C18:1 and C18:3 FAs, although the degree of increase was not equivalent across the FA spectrum analyzed, perhaps due to altered regulation of FabR as noted above. Notably we observed a shift from medium towards long chain FAs with levels of C16 and C18:1 and C18:3 FAs increasing approximately 3-fold which also represented a greater fraction of the total FA pool (Additional file 4: Figure S2).
Next, we examined the effect of Csr perturbation on the production of target compounds from various codon-optimized heterologous pathways. Since the heterologous pathways for n-butanol and amorphadiene production both employ acetyl-CoA as a branch-point precursor (Figure 4b and Figure 4c), we hypothesized that the enhanced acetyl-CoA pool afforded by CsrB-mediated regulation might increase production titers. n-Butanol can be produced using a four-gene pathway derived from Clostridium acetobutylicum[41, 42], while amorphadiene is synthesized through the five-gene mevalonate pathway from Saccharomyces cerevisiae in conjunction with the corresponding synthase from Artemisia annua (see Additional file 1: Table S1 for details on parts and composition). We found that CsrB-mediated regulation enhanced total n-butanol production from 48 mg/L to 90 mg/L, an 88% increase, when cells were induced with 20 mM arabinose. Total production of amorphadiene increased 55% (from 60 mg/L to 93 mg/L in 48 h).
A proposed model of regulatory interplay connecting Csr and stringent response systems in E. coli involves the transcription factor DksA and the nucleotide secondary messenger ppGpp . These activate csrB/C transcription to relieve CsrA mediated regulation during stringent response . In the current study, we examined the impact of directly elevating CsrB levels thereby bypassing this native regulatory machinery. We performed a systems level analysis to assess the global impact of the aforesaid perturbation. Our proteomics and metabolomics analyses suggest that induced CsrB elevation results in the accumulation of glycolytic intermediates. In particular, we observed that CsrB-mediated deregulation of CsrA drives overexpression of the CsrA-targeted glgCAP operon (Figure 2), which would result in the accretion of the storage polysaccharide glycogen. Other alterations in central carbon metabolism included dramatic increases in the levels of acetyl-CoA and several amino acids, with concurrent decrease in acetate levels (Additional file 6: Table S3).
We also found that CsrB impacts the expression of the stringent response regulator DksA (Additional file 2: Table S2). DksA is responsible for transcriptional activation of CsrB (and therefore indirect deregulation of CsrA) during stringent response . Additionally, we found a CsrA binding-site in the 5’UTR of DksA. This suggests that CsrB (through CsrA) directly regulates DksA, thereby forming a positive feedback loop. This model would predict that increased CsrB levels should also increase levels of DksA. In fact, we found that elevation of CsrB levels produced a 2.5-fold increase in protein levels of DksA. While a previous study  has shown that increased DksA expression transcriptionally activates CsrB/C, our findings strongly suggest that a post-transcriptional positive feedback loop also links CsrA/B and the stringent response regulator DksA.
Classic symptoms of the stringent response  such as increased amino acid biosynthesis and decreased ribosomal protein production (Additional file 2: Table S2) also appear to be amplified by CsrB overexpression. These complement typical features of the Csr system  such as increased carbon metabolism and motility (Additional file 2: Table S2) among others. Our findings suggest that ectopic amplification of CsrB in E. coli somewhat mimics the conditions of stringent response in that resources are diverted away from cellular growth and division and towards amino acid synthesis. This was evidenced by a near universal increase in amino-acid levels as exemplified by a 44-fold increase in asparagine levels. Interestingly, we also noted that CsrB elevation also significantly modulated the protein expression of the ArcA regulon (P < 0.005) which has previously been implicated in stringent response . These results further strengthen the proposed link between Csr and the stringent response .
While it is possible that catabolism of isoleucine present in the medium might account for some of the improved compound production and carbon redistribution observed, we believe this effect to be marginal. In support of this, we observed an insignificant decrease in intracellular isoleucine levels (1.4-fold, P ~ 0.1) between test and control strains. Additionally, we observed no evidence for changing protein levels or CsrA binding sites among genes involved in protein recycling or proteolysis.
Given the ubiquity of engineered pathways that rely on glycolysis for producing biologically-derived compounds, results from this study would be expected to have broad implications. Indeed, we demonstrated improved hydrocarbon production through three distinct routes engineered for generating advanced biofuels by simple manipulation of this ribonucleoprotein regulatory scheme in E. coli. While it is tempting to speculate that the increased amino acid levels due to CsrB elevation may also be used to improve biofuel production through synthetic non-fermentative pathways , such validation remains to be performed.
This approach obviates the need for extensive host organism modification in simply requiring overexpression of a single non-coding RNA. It remains to be seen if such an approach can be applied synergistically with other approaches for improving production. As such, this study shows that targeting of the carbon storage regulator and stringent response systems can be a powerful means with which to increase targeted compound production in metabolic engineering applications. This approach is likely generalizable to other pathways and organisms.
Materials and methods
E. coli DH5a (F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoRnupG Φ80dlacZ ΔM15 Δ(lacZYA-argF)U169, hsdR17(rK-mK+), λ–) was used for cloning and DNA amplification. E. coli strain BLR (ΔtyrR; ΔpheA/L; aroF[P148L]; tyrA[M53I; A354V]) [36, 47, 48] was used as the base strain (BLR-DAJ) in this study. This strain is auxotrophic for phenylalanine and isoleucine .
Plasmids for advanced biofuel production
CsrB was amplified from E. coli MG1655 using primers CsrB_F/R. Restriction enzymes BamHI and XhoI were used to insert CsrB into the medium copy vectors pBbA5A and pBbB5C, with the lacUV5 promoter (PlacUV5) and the chloramphenicol or ampicillin resistance genes, respectively. The C. acetobutylicum butyryl-CoA biosynthetic operon (crt hbd etfAB hbd) and alcohol dehydrogenase (adhE2) were amplified from C. acetobutylicum ATCC824 genomic DNA (ATCC) using primers F76/F73 and F72/F74, respectively. The vector backbone (containing a p15a origin), chloramphenicol selective marker, trc promoter (Ptrc), and LacIQ was amplified using primers F75/F77. The three PCR products were assembled using the SLIC protocol , producing plasmid pBMO49. The atoB gene from E. coli (PCR amplified using primers F92/F93) and an additional Ptrc promoter (PCR amplified using primers F90/F91) were inserted 5’ of adhE2 to generate plasmid pBMO50 using BglII and BamHI restriction sites. Plasmids for fatty acid production  and amorphadiene production  and the respective extraction procedures are described elsewhere.
Medium composition and growth conditions
Individual colonies were grown overnight at 37°C in LB medium and passed 1:100 for an additional night of growth in Neidhardt MOPS medium containing 0.5 or 1.0% glucose for metabolite analysis or heterologous pathway production experiments, respectively. Glucose was the sole carbon source used in all production experiments. All metabolite production experiments were carried out in defined media (Neidhardt MOPS)  supplemented with 12.5 g/L  and 10.0 g/L phenylalanine. E. coli were seeded at 1:100 dilutions into either 5-mL shake tubes or 50-ml shake flasks (metabolomics experiments) and grown at 30°C or 37°C with appropriate antibiotics. IPTG (Sigma-Aldrich) was added at the concentrations indicated to induce CsrB. Except where noted, all metabolite and production data were collected at 48 hrs after induction. All data presented are the averaged results of biological triplicates.
Proteomics sample preparation & analysis
Cells were centrifuged at 8000 × g at 4°C and frozen in liquid nitrogen. Protein extraction was performed using chloroform/methanol (Wessel and Flugge, 1984) followed by desiccation in a vacuum concentrator (ThermoSavant). Samples were reconstituted in 200 μL of 100 mM ammonium bicarbonate with 20% (v/v) methanol to a final concentration of 0.25 μg/μL. Disulfide bonds were reduced with 5 mM TCEP for 30 minutes, and alkylation was performed with 200 mM iodoacetic acid for 30 minutes in the dark. Trypsin (1 μg/μL) was added to a final concentration of 1:50 (trypsin:sample), and incubated at 37°C overnight.
Samples were washed for 10 min at a 15 μL/min flow rate with a buffer consisting of 94% (v/v) acetonitrile, 0.1% (v/v) formic acid and 5.9% H2O on a Pepmap100 μ-guard column (Dionex-LC Packings, Sunnyvale, CA). Samples were then applied to a Pepmap100 analytical column (75-μm i.d., 150-mm length, 100 Å, and 3 μm) for 60 minutes at a flow rate of 300 nL/min. Column pressure was equilibrated with buffer for two minutes. Samples were analyzed on a LC-MS/MS system consisting of an Eksigent TEMPO nanoLC-2D coupled to an AB Sciex (Foster City, CA) 5600 Triple-TOF mass spectrometer running Analyst TF™ 1.5.1 (AB Sciex) in IDA experiment mode.
Spectra were processed using PeakView v22.214.171.124 (AB Sciex), analyzed with Mascot 2.2 (Matrix Science) and imported in Scaffold v3.2.0 (Proteome Software Inc, Portland, OR USA) for analysis. A database of all E. coli ORFs (MicrobesOnline) was searched using a peptide tolerance of 100 ppm, allowing for 1 missed trypsin cleavage and carboxymethyl modifications. Proteins were identified with at least two 95% confidence peptides. For analysis of fold changes, only proteins with at least five spectral counts were considered.
Sampling, quenching, and extraction of metabolites
Separation of metabolites for the analysis of glycolysis and TCA cycle intermediates was conducted on a fermentation monitoring HPX-87 H column with 8% cross linkage (150-mm length, 7.8-mm internal diameter, and 9-μm particle size; Biorad, CA, USA). Pyruvate separation was conducted on a ZIC-HILIC column (250-mm length, 2.1-mm internal diameter, and 3.5-μm particle size; Merck SeQuant, MA, USA). Samples were run on an Agilent Technologies 1100 Series HPLC (Agilent Technologies, CA, USA).
For analysis of amino acids, CE separations were performed in a 100 cm, 50-μ m i.d. ~365-μ m o.d. (total volume 1963 nL), untreated, fused-silica capillary (PolyMicro Technologies) via the Agilent CE system (Agilent Technologies). Details on subsequent experimental protocols are provided in the Supplemental Methods.
Motif analyses and statistical testing
Using experimentally determined CsrA binding sites from previous studies [23, 52–55] and our proteomics results, we identified genome wide targets putatively regulated by CsrA. Details of this motif analyses are provided in Supplemental Methods. Tests for statistical enrichment of motifs and functional categories were performed using the hypergeometric enrichment test . Multiple-test correction of test statistics was performed using the Benjamini-Hochberg method . Gene ontology annotations were obtained from AMIGO  while TIGR gene indices were obtained from Microbes Online .
Experimental work was performed by AEM, BJR, DCC, EKB, DJ, DK, PIB, JAD, and SMM. DK, DCC and CJP analyzed the data. APA, CJP, APA CJP, PDA, JDK and SRC supervised the study. DK and SRC wrote the final manuscript. All authors read and approved the final manuscript.
Carbon storage regulator
Fatty acid methyl ester
The Institute for Genomic Research
Polymerase chain reaction
Open reading frame
- E. coli:
Lam FH, Hartner FS, Fink GR, Stephanopoulos G: Enhancing stress resistance and production phenotypes through transcriptome engineering. Methods Enzymol. 2010, 470: 509-532.
Alper H, Moxley J, Nevoigt E, Fink GR, Stephanopoulos G: Engineering yeast transcription machinery for improved ethanol tolerance and production. Science. 2006, 314: 1565-1568. 10.1126/science.1131969.
Yu H, Tyo K, Alper H, Klein-Marcuschamer D, Stephanopoulos G: A high-throughput screen for hyaluronic acid accumulation in recombinant Escherichia coli transformed by libraries of engineered sigma factors. Biotechnol Bioeng. 2008, 101: 788-796. 10.1002/bit.21947.
Klein-Marcuschamer D, Santos CN, Yu H, Stephanopoulos G: Mutagenesis of the bacterial RNA polymerase alpha subunit for improvement of complex phenotypes. Appl Environ Microbiol. 2009, 75: 2705-2711. 10.1128/AEM.01888-08.
Lee JY, Yang KS, Jang SA, Sung BH, Kim SC: Engineering butanol-tolerance in escherichia coli with artificial transcription factor libraries. Biotechnol Bioeng. 2011, 108: 742-749. 10.1002/bit.22989.
Edwards AN, Patterson-Fortin LM, Vakulskas CA, Mercante JW, Potrykus K, Vinella D, Camacho MI, Fields JA, Thompson SA, Georgellis D, et al: Circuitry linking the Csr and stringent response global regulatory systems. Mol Microbiol. 2011, 80: 1561-1580. 10.1111/j.1365-2958.2011.07663.x.
Romeo T: Global regulation by the small RNA-binding protein CsrA and the non-coding RNA molecule CsrB. Mol Microbiol. 1998, 29: 1321-1330. 10.1046/j.1365-2958.1998.01021.x.
Timmermans J, Van Melderen L: Post-transcriptional global regulation by CsrA in bacteria. Cell Mol Life Sci. 2010, 67: 2897-2908. 10.1007/s00018-010-0381-z.
Jonas K, Edwards AN, Ahmad I, Romeo T, Romling U, Melefors O: Complex regulatory network encompassing the Csr, c-di-GMP and motility systems of Salmonella Typhimurium. Environ Microbiol. 2010, 12: 524-540. 10.1111/j.1462-2920.2009.02097.x.
Yakhnin H, Pandit P, Petty TJ, Baker CS, Romeo T, Babitzke P: CsrA of Bacillus subtilis regulates translation initiation of the gene encoding the flagellin protein (hag) by blocking ribosome binding. Mol Microbiol. 2007, 64: 1605-1620. 10.1111/j.1365-2958.2007.05765.x.
Tatarko M, Romeo T: Disruption of a global regulatory gene to enhance central carbon flux into phenylalanine biosynthesis in Escherichia coli. Curr Microbiol. 2001, 43: 26-32. 10.1007/s002840010255.
Yakandawala N, Romeo T, Friesen AD, Madhyastha S: Metabolic engineering of Escherichia coli to enhance phenylalanine production. Appl Microbiol Biotechnol. 2008, 78: 283-291. 10.1007/s00253-007-1307-z.
Romeo T, Gong M: Genetic and physical mapping of the regulatory gene csrA on the Escherichia coli K-12 chromosome. J Bacteriol. 1993, 175: 5740-5741.
Romeo T, Gong M, Liu MY, Brun-Zinkernagel AM: Identification and molecular characterization of csrA, a pleiotropic gene from Escherichia coli that affects glycogen biosynthesis, gluconeogenesis, cell size, and surface properties. J Bacteriol. 1993, 175: 4744-4755.
Romeo T: Post-transcriptional regulation of bacterial carbohydrate metabolism: evidence that the gene product CsrA is a global mRNA decay factor. Res Microbiol. 1996, 147: 505-512. 10.1016/0923-2508(96)84004-6.
Shine J, Dalgarno L: The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites. Proc Natl Acad Sci USA. 1974, 71: 1342-1346. 10.1073/pnas.71.4.1342.
Sabnis NA, Yang H, Romeo T: Pleiotropic regulation of central carbohydrate metabolism in Escherichia coli via the gene csrA. J Biol Chem. 1995, 270: 29096-29104. 10.1074/jbc.270.49.29096.
Timmermans J, Van Melderen L: Conditional essentiality of the csrA gene in Escherichia coli. J Bacteriol. 2009, 191: 1722-1724. 10.1128/JB.01573-08.
Liu MY, Gui G, Wei B, 3rd Preston JF, Oakford L, Yuksel U, Giedroc DP, Romeo T: The RNA molecule CsrB binds to the global regulatory protein CsrA and antagonizes its activity in Escherichia coli. J Biol Chem. 1997, 272: 17502-17510. 10.1074/jbc.272.28.17502.
Babitzke P, Romeo T: CsrB sRNA family: sequestration of RNA-binding regulatory proteins. Curr Opin Microbiol. 2007, 10: 156-163. 10.1016/j.mib.2007.03.007.
Weilbacher T, Suzuki K, Dubey AK, Wang X, Gudapaty S, Morozov I, Baker CS, Georgellis D, Babitzke P, Romeo T: A novel sRNA component of the carbon storage regulatory system of Escherichia coli. Mol Microbiol. 2003, 48: 657-670. 10.1046/j.1365-2958.2003.03459.x.
Gutierrez P, Li Y, Osborne MJ, Pomerantseva E, Liu Q, Gehring K: Solution structure of the carbon storage regulator protein CsrA from Escherichia coli. J Bacteriol. 2005, 187: 3496-3501. 10.1128/JB.187.10.3496-3501.2005.
Baker CS, Morozov I, Suzuki K, Romeo T, Babitzke P: CsrA regulates glycogen biosynthesis by preventing translation of glgC in Escherichia coli. Mol Microbiol. 2002, 44: 1599-1610. 10.1046/j.1365-2958.2002.02982.x.
Wei BL, Brun-Zinkernagel AM, Simecka JW, Pruss BM, Babitzke P, Romeo T: Positive regulation of motility and flhDC expression by the RNA-binding protein CsrA of Escherichia coli. Mol Microbiol. 2001, 40: 245-256. 10.1046/j.1365-2958.2001.02380.x.
Dehal PS, Joachimiak MP, Price MN, Bates JT, Baumohl JK, Chivian D, Friedland GD, Huang KH, Keller K, Novichkov PS, et al: MicrobesOnline: an integrated portal for comparative and functional genomics. Nucleic Acids Res. 2010, 38: D396-400. 10.1093/nar/gkp919.
Gama-Castro S, Salgado H, Peralta-Gil M, Santos-Zavaleta A, Muniz-Rascado L, Solano-Lira H, Jimenez-Jacinto V, Weiss V, Garcia-Sotelo JS, Lopez-Fuentes A, et al: RegulonDB version 7.0: transcriptional regulation of Escherichia coli K-12 integrated within genetic sensory response units (Gensor Units). Nucleic Acids Res. 2011, 39: D98-105. 10.1093/nar/gkq1110.
Quan JA, Schneider BL, Paulsen IT, Yamada M, Kredich NM, Saier MH: Regulation of carbon utilization by sulfur availability in Escherichia coli and Salmonella typhimurium. Microbiology. 2002, 148: 123-131.
Maloy SR, Nunn WD: Genetic regulation of the glyoxylate shunt in Escherichia coli K-12. J Bacteriol. 1982, 149: 173-180.
Bond-Watts BB, Bellerose RJ, Chang MC: Enzyme mechanism as a kinetic control element for designing synthetic biofuel pathways. Nat Chem Biol. 2011, 7: 222-227. 10.1038/nchembio.537.
Ma SM, Garcia DE, Redding-Johanson AM, Friedland GD, Chan R, Batth TS, Haliburton JR, Chivian D, Keasling JD, Petzold CJ, et al: Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. Metab Eng. 2011, 13: 588-597. 10.1016/j.ymben.2011.07.001.
Redding-Johanson AM, Batth TS, Chan R, Krupa R, Szmidt HL, Adams PD, Keasling JD, Lee TS, Mukhopadhyay A, Petzold CJ: Targeted proteomics for metabolic pathway optimization: application to terpene production. Metab Eng. 2011, 13: 194-203. 10.1016/j.ymben.2010.12.005.
Peralta-Yahya PP, Keasling JD: Advanced biofuel production in microbes. Biotechnol J. 2010, 5: 147-162. 10.1002/biot.200900220.
Clomburg JM, Gonzalez R: Biofuel production in Escherichia coli: the role of metabolic engineering and synthetic biology. Appl Microbiol Biotechnol. 2010, 86: 419-434. 10.1007/s00253-010-2446-1.
Zhu K, Zhang YM, Rock CO: Transcriptional regulation of membrane lipid homeostasis in Escherichia coli. J Biol Chem. 2009, 284: 34880-34888. 10.1074/jbc.M109.068239.
Xu Y, Heath RJ, Li Z, Rock CO, White SW: The FadR.DNA complex. Transcriptional control of fatty acid metabolism in Escherichia coli. J Biol Chem. 2001, 276: 17373-17379. 10.1074/jbc.M100195200.
Olson MM, Templeton LJ, Suh W, Youderian P, Sariaslani FS, Gatenby AA, Van Dyk TK: Production of tyrosine from sucrose or glucose achieved by rapid genetic changes to phenylalanine-producing Escherichia coli strains. Appl Microbiol Biotechnol. 2007, 74: 1031-1040. 10.1007/s00253-006-0746-2.
Steen EJ, Kang Y, Bokinsky G, Hu Z, Schirmer A, McClure A, Del Cardayre SB, Keasling JD: Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature. 2010, 463: 559-562. 10.1038/nature08721.
Jiang P, Cronan JE: Inhibition of fatty acid synthesis in Escherichia coli in the absence of phospholipid synthesis and release of inhibition by thioesterase action. J Bacteriol. 1994, 176: 2814-2821.
Cho H, Cronan JE: Defective export of a periplasmic enzyme disrupts regulation of fatty acid synthesis. J Biol Chem. 1995, 270: 4216-4219. 10.1074/jbc.270.9.4216.
Lu X, Vora H, Khosla C: Overproduction of free fatty acids in E. coli: implications for biodiesel production. Metab Eng. 2008, 10: 333-339. 10.1016/j.ymben.2008.08.006.
Atsumi S, Cann AF, Connor MR, Shen CR, Smith KM, Brynildsen MP, Chou KJ, Hanai T, Liao JC: Metabolic engineering of Escherichia coli for 1-butanol production. Metab Eng. 2008, 10: 305-311. 10.1016/j.ymben.2007.08.003.
Nielsen DR, Leonard E, Yoon SH, Tseng HC, Yuan C, Prather KL: Engineering alternative butanol production platforms in heterologous bacteria. Metab Eng. 2009, 11: 262-273. 10.1016/j.ymben.2009.05.003.
Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD: Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol. 2003, 21: 796-802. 10.1038/nbt833.
Traxler MF, Summers SM, Nguyen HT, Zacharia VM, Hightower GA, Smith JT, Conway T: The global, ppGpp-mediated stringent response to amino acid starvation in Escherichia coli. Mol Microbiol. 2008, 68: 1128-1148. 10.1111/j.1365-2958.2008.06229.x.
Chang DE, Smalley DJ, Conway T: Gene expression profiling of Escherichia coli growth transitions: an expanded stringent response model. Mol Microbiol. 2002, 45: 289-306. 10.1046/j.1365-2958.2002.03001.x.
Atsumi S, Hanai T, Liao JC: Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature. 2008, 451: 86-89. 10.1038/nature06450.
Weaver LM, Herrmann KM: Cloning of an aroF allele encoding a tyrosine-insensitive 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase. J Bacteriol. 1990, 172: 6581-6584.
Lutke-Eversloh T, Stephanopoulos G: L-tyrosine production by deregulated strains of Escherichia coli. Appl Microbiol Biotechnol. 2007, 75: 103-110. 10.1007/s00253-006-0792-9.
Schmidt M, Romer L, Strehle M, Scheibel T: Conquering isoleucine auxotrophy of Escherichia coli BLR(DE3) to recombinantly produce spider silk proteins in minimal media. Biotechnol Lett. 2007, 29: 1741-1744. 10.1007/s10529-007-9461-z.
Li MZ, Elledge SJ: Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC. Nat Methods. 2007, 4: 251-256. 10.1038/nmeth1010.
Neidhardt FC, Bloch PL, Smith DF: Culture medium for enterobacteria. J Bacteriol. 1974, 119: 736-747.
Baker CS, Eory LA, Yakhnin H, Mercante J, Romeo T, Babitzke P: CsrA inhibits translation initiation of Escherichia coli hfq by binding to a single site overlapping the Shine-Dalgarno sequence. J Bacteriol. 2007, 189: 5472-5481. 10.1128/JB.00529-07.
Dubey AK, Baker CS, Suzuki K, Jones AD, Pandit P, Romeo T, Babitzke P: CsrA regulates translation of the Escherichia coli carbon starvation gene, cstA, by blocking ribosome access to the cstA transcript. J Bacteriol. 2003, 185: 4450-4460. 10.1128/JB.185.15.4450-4460.2003.
Jonas K, Edwards AN, Simm R, Romeo T, Romling U, Melefors O: The RNA binding protein CsrA controls cyclic di-GMP metabolism by directly regulating the expression of GGDEF proteins. Mol Microbiol. 2008, 70: 236-257. 10.1111/j.1365-2958.2008.06411.x.
Wang X, Dubey AK, Suzuki K, Baker CS, Babitzke P, Romeo T: CsrA post-transcriptionally represses pgaABCD, responsible for synthesis of a biofilm polysaccharide adhesin of Escherichia coli. Mol Microbiol. 2005, 56: 1648-1663. 10.1111/j.1365-2958.2005.04648.x.
Rivals I, Personnaz L, Taing L, Potier MC: Enrichment or depletion of a GO category within a class of genes: which test?. Bioinformatics. 2007, 23: 401-407. 10.1093/bioinformatics/btl633.
Benjamini Y, Hochberg Y: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995, 57: 289-300.
Keseler IM, Collado-Vides J, Santos-Zavaleta A, Peralta-Gil M, Gama-Castro S, Muniz-Rascado L, Bonavides-Martinez C, Paley S, Krummenacker M, Altman T, et al: EcoCyc: a comprehensive database of Escherichia coli biology. Nucleic Acids Res. 2011, 39: D583-590. 10.1093/nar/gkq1143.
This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the US Department of Energy under Contract no. DE-AC02-05CH11231.
JDK has financial interests in Amyris and LS9, both of which are involved in producing advanced biofuels.
Adrienne E McKee, Becky J Rutherford, Dylan C Chivian, Edward K Baidoo, Darmawi Juminaga, Dwight Kuo and Swapnil R Chhabra contributed equally to this work.